IDSA Guidance for the Treatment of Antimicrobial-Resistant Gram-Negative Infections

Purpose

The purpose of developing IDSA clinical guidance is to assist clinicians in making treatment decisions.

An update to the IDSA Guidance for the Treatment of Antimicrobial-Resistant Gram-Negative Infections will begin in 2023 (for publication as the 2024 version of the guidance). For the update, IDSA is looking for two to three infectious diseases-trained physician or pharmacist experts to join the panel.

Responsibilities

• Actively participate in the evidence identification and literature review process.
• Generate specific clinical guidance statements based on the best available evidence.
• Assist in drafting and critically reviewing the manuscript.
• Participate in and adhere to the principles of IDSA-provided training on guidance development.

Required Qualifications

• Relevant clinical expertise related to the guidance topic.
• Extensive familiarity with the published literature related to the guidance topic.
• Good organizational skills and attention to detail.
• Demonstrated ability to bring tasks/initiatives to completion.
• Open-minded and collaborative, with a commitment to the formal consensus building process.

How to Apply

• Complete the application, which includes a section describing your interest in serving as a panel member and your relevant experience for this project.
• Upload your resume or CV.
• Upload your completed conflict of interest disclosure form (PDF). **Please complete this form before proceeding to the next page.**

Guidance Development Timeline and Meeting Frequency

IDSA strives to complete most guidance within 12-18 months. Therefore, it is critical that the chair and panel members be committed to the completion of a guidance within the expected timeframe. Panel meetings will be held as virtual meetings. The panel will likely hold 10-12 virtual meetings throughout the 2023 calendar year.

Estimated Time Commitment

10-20 hours per month; time commitments will vary depending on the stage of guidance development.

Appointment

The panel chairs will identify prospective panel members, who will be reviewed and approved by the Standards and Practice Guidelines Committee chair and Board liaison. Participation on the guidance panel will only be confirmed following review of potential conflicts of interest. Applicants will be notified of final decisions within 4-6 weeks.